Phathom Pharmaceuticals (PHAT)
(Delayed Data from NSDQ)
$9.18 USD
+0.08 (0.88%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $9.19 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -1.13 |
EPS Last Quarter | -0.80 |
Last EPS Surprise | 13.04% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.22 |
Next Year | -3.24 |
EPS (TTM) | -3.29 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.50M | 7.35M | 44.72M | 138.65M |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 3.50M | 7.35M | 45.49M | 144.17M |
Low Estimate | 3.50M | 7.35M | 43.95M | 133.12M |
Year ago Sales | 0.00M | 0.00M | 0.68M | 44.72M |
Year over Year Growth Est. | NA | NA | 6,457.28% | 210.03% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.13 | -1.10 | -4.22 | -3.24 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -1.09 | -1.08 | -4.21 | -3.05 |
High Estimate | -1.09 | -1.08 | -4.21 | -3.05 |
Low Estimate | -1.16 | -1.11 | -4.22 | -3.42 |
Year ago EPS | -0.89 | -0.84 | -2.53 | -4.22 |
Year over Year Growth Est. | -26.97% | -30.95% | -66.80% | 23.22% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.13 | -1.10 | -4.22 | -3.24 |
7 Days Ago | -1.13 | -1.10 | -4.22 | -3.24 |
30 Days Ago | -1.13 | -1.10 | -4.22 | -3.24 |
60 Days Ago | NA | NA | -4.15 | -3.25 |
90 Days Ago | NA | NA | -4.15 | -3.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.13 | -1.10 | -4.22 | -3.24 |
Zacks Consensus Estimate | -1.13 | -1.10 | -4.22 | -3.24 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.80 | -0.76 | -0.84 | -0.89 | NA |
Estimate | -0.92 | -0.95 | -0.95 | -1.34 | NA |
Difference | 0.12 | 0.19 | 0.11 | 0.45 | 0.22 |
Surprise | 13.04% | 20.00% | 11.58% | 33.58% | 19.55% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more